Position in ASND
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$81,563,776
+$31,165,180 QoQ
Shares Held
305,803
+38.8% QoQ
Ownership
0.466%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#31
of 307 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Derivatives in ASND
reported options exposure · as of Jun 30, 2026CallValue
$373,408
CallShares
1,400
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026TWO SIGMA INVESTMENTS, LP holds $7,273,657,992 across 342 Biotechnology names. ASND ranks #29 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,875,937 | $564,713,315 | |
| 2 | MRNA |
Moderna, Inc.
|
7,193,530 | $503,762,905 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
6,252,342 | $495,748,197 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
656,124 | $409,119,558 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
4,722,185 | $351,708,338 | |
| 6 | EXEL |
Exelixis, Inc.
|
4,209,861 | $229,058,537 | |
| 7 | INCY |
Incyte Corp
|
2,003,559 | $227,123,448 | |
| 8 | ARGX |
Argenx SE
|
185,638 | $172,229,367 |
All Filings in ASND
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $81,563,776 | 305,803 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $373,408 | 1,400 | Call | Sole | 2026-08-14 | |
| 2026-03-31 | $320,222 | 1,400 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $50,398,596 | 220,341 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $846,301 | 3,700 | Put | Sole | 2026-05-15 | |
| 2025-12-31 | $52,860,490 | 247,892 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $36,558,375 | 183,886 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $537,649 | 3,115 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,924,089 | 18,761 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,502,668 | 10,915 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,478,639 | 50,088 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $34,820,541 | 255,320 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $31,794,830 | 210,325 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||